KTE-C19

tisagenlecleucel · Kite, a Gilead Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KTE-C19, covering 2020-06-26 to 2020-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety and Efficacy of KTE-C19 in Combination With Atezolizumab in Adults With Refractory Diffuse Large B-Cell Lymphoma (DLBCL) [Phase 1, Phase 2]

See pricing